SCHEMBL2810066

SCHEMBL2810066

CC1(CO)CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29813212 1.00
SCHEMBL29441195 0.81
SCHEMBL2002220 0.81
SCHEMBL10876938 0.79
SCHEMBL3422565 0.78
SCHEMBL16369916 0.78 MAPT (0.32)
SCHEMBL16369919 0.78 MAPT (0.32)
SCHEMBL16369918 0.78 MAPT (0.32)
SCHEMBL3810403 0.75
SCHEMBL627879 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101484506-B Polyhydroxyfunktional polysiloxanes, method for the production and use thereof BYK CHEMIE GMBH 2012-06-06 CN claimed
CN-102089355-A Polyhydroxyfunctional polysiloxanes for increasing the surface energy of thermoplastics, method for production and use thereof BYK CHEMIE GMBH 2011-06-08 CN claimed
CN-101484506-A Polyhydroxyfunktional polysiloxanes, method for the production and use thereof BYK CHEMIE GMBH (DE) 2009-07-15 CN claimed
CN-1258517-C Process for preparing acrylic ester (methacrylic) DSM IP PROPERTY N V (NL) 2006-06-07 CN claimed
CN-1434020-A Process for preparing acrylic ester (methacrylic) DSM NV (NL) 2003-08-06 CN claimed
US-H991-H Synthesis of nitratomethylmethyloxetane (NMMO) THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1991-11-05 US claimed
EP-4126861-B1 3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER BAYER AG (DE) 2025-06-18 EP disclosed
US-20240307362-A1 4H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2024-09-19 US disclosed
US-11999699-B2 Substituted pyrazole amides Grünenthal GmbH (DE) 2024-06-04 US disclosed
US-20240140957-A1 BRIDGED COMPOUNDS AS KRAS G12D INHIBITOR AND DEGRADER AND THE USE THEREOF BEONE MEDICINES I GMBH (CH) 2024-05-02 US disclosed
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed
US-20230064983-A1 3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER BAYER AKTIENGESELLSCHAFT (DE) 2023-03-02 US disclosed
EP-4126861-A1 3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Bayer Aktiengesellschaft (DE) 2023-02-08 EP disclosed
CN-101155853-A Radiation or heat curable oxetane barrier sealants RPORATION NAT STARCH AND CHEMI (US) 2008-04-02 CN disclosed
CN-1258517-C Process for preparing acrylic ester (methacrylic) DSM IP PROPERTY N V (NL) 2006-06-07 CN disclosed
US-20040214945-A1 Catioinically polymerizable composition and ink RISO KAGAKU CORPORATION (JP) 2004-10-28 US disclosed
CN-1434020-A Process for preparing acrylic ester (methacrylic) DSM NV (NL) 2003-08-06 CN disclosed
US-20020146573-A1 Polymer composition, cured product, laminate and method for producing the cured product JSR CORPORATION (JP) 2002-10-10 US disclosed
EP-1229092-A2 Polymer composition, cured product, laminate and method for producing the cured product JSR Corporation (JP) 2002-08-07 EP disclosed
US-H991-H Synthesis of nitratomethylmethyloxetane (NMMO) THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1991-11-05 US disclosed